Baxter RP - Search Results

1

Live Attenuated Influenza Vaccination Before 3 Years of Age and Subsequent Development of Asthma: A 14-year Follow-up Study.

Baxter RP, Lewis N, Fireman B, Hansen J, Klein NP, Ortiz JR. Baxter RP, et al. Pediatr Infect Dis J. 2018 May;37(5):383-386. doi: 10.1097/INF.0000000000001783. Pediatr Infect Dis J. 2018. PMID: 28914750 Free PMC article. Clinical Trial.

2

Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.

Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B. Black S, et al. Pediatr Infect Dis J. 2004 Jun;23(6):485-9. doi: 10.1097/01.inf.0000129685.04847.94. Pediatr Infect Dis J. 2004. PMID: 15194827

3

Influenza vaccination and mortality: differentiating vaccine effects from bias.

Fireman B, Lee J, Lewis N, Bembom O, van der Laan M, Baxter R. Fireman B, et al. Am J Epidemiol. 2009 Sep 1;170(5):650-6. doi: 10.1093/aje/kwp173. Epub 2009 Jul 22. Am J Epidemiol. 2009. PMID: 19625341 Free PMC article.

4

Evidence of bias in studies of influenza vaccine effectiveness in elderly patients.

Baxter R, Lee J, Fireman B. Baxter R, et al. J Infect Dis. 2010 Jan 15;201(2):186-9. doi: 10.1086/649568. J Infect Dis. 2010. PMID: 19995265

5

Effect of influenza vaccination on hospitalizations in persons aged 50 years and older.

Baxter R, Ray GT, Fireman BH. Baxter R, et al. Vaccine. 2010 Oct 21;28(45):7267-72. doi: 10.1016/j.vaccine.2010.08.088. Epub 2010 Sep 9. Vaccine. 2010. PMID: 20832494

6

Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccines among persons 15-59 years of age.

Ray P, Black S, Shinefield H, Dillon A, Carpenter D, Lewis E, Ross P, Chen RT, Klein NP, Baxter R; Vaccine Safety Datalink Team. Ray P, et al. Vaccine. 2011 Sep 2;29(38):6592-7. doi: 10.1016/j.vaccine.2011.06.112. Epub 2011 Jul 16. Vaccine. 2011. PMID: 21763385

7

Recurrent Guillain-Barre syndrome following vaccination.

Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP; CISA Network. Baxter R, et al. Clin Infect Dis. 2012 Mar;54(6):800-4. doi: 10.1093/cid/cir960. Epub 2012 Jan 19. Clin Infect Dis. 2012. PMID: 22267712

8

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in children 5 through 17 years of age.

Baxter R, Toback SL, Sifakis F, Hansen J, Bartlett J, Aukes L, Lewis N, Wu X, Ambrose CS. Baxter R, et al. Vaccine. 2012 Apr 19;30(19):2989-98. doi: 10.1016/j.vaccine.2012.02.039. Epub 2012 Feb 29. Vaccine. 2012. PMID: 22386746 Free article.

9

A postmarketing evaluation of the safety of Ann Arbor strain live attenuated influenza vaccine in adults 18-49 years of age.

Baxter R, Toback SL, Sifakis F, Hansen J, Bartlett J, Aukes L, Lewis N, Wu X, Ambrose CS. Baxter R, et al. Vaccine. 2012 Apr 26;30(20):3053-60. doi: 10.1016/j.vaccine.2012.02.080. Epub 2012 Mar 13. Vaccine. 2012. PMID: 22425787 Free article.

10

Safety of Zostavax™--a cohort study in a managed care organization.

Baxter R, Tran TN, Hansen J, Emery M, Fireman B, Bartlett J, Lewis N, Saddier P. Baxter R, et al. Vaccine. 2012 Oct 19;30(47):6636-41. doi: 10.1016/j.vaccine.2012.08.070. Epub 2012 Sep 8. Vaccine. 2012. PMID: 22963800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters